Correlation Between Acutus Medical and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acutus Medical and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acutus Medical and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acutus Medical and Immunoprecise Antibodies, you can compare the effects of market volatilities on Acutus Medical and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acutus Medical with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acutus Medical and Immunoprecise Antibodies.

Diversification Opportunities for Acutus Medical and Immunoprecise Antibodies

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Acutus and Immunoprecise is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Acutus Medical and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Acutus Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acutus Medical are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Acutus Medical i.e., Acutus Medical and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Acutus Medical and Immunoprecise Antibodies

Given the investment horizon of 90 days Acutus Medical is expected to generate 3.02 times more return on investment than Immunoprecise Antibodies. However, Acutus Medical is 3.02 times more volatile than Immunoprecise Antibodies. It trades about 0.01 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.07 per unit of risk. If you would invest  139.00  in Acutus Medical on March 31, 2022 and sell it today you would lose (41.00)  from holding Acutus Medical or give up 29.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Acutus Medical  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
Acutus Medical 
Acutus Performance
0 of 100
Over the last 90 days Acutus Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Acutus Medical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Acutus Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in July 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Immunoprecise Price Channel

Acutus Medical and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Acutus Medical and Immunoprecise Antibodies

The main advantage of trading using opposite Acutus Medical and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acutus Medical position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.
The idea behind Acutus Medical and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go